Table 4.
Analyses of diastolic blood pressure.
| Trials | MD [95% CI] | P Value | |
|---|---|---|---|
| YQG plus valsartan versus valsartan | 1 | −11.70 [−13.70, −9.70] | <0.00001 |
| YQG plus antihypertensive drugs versus antihypertensive drugs | 1 | −8.00 [−9.03, −6.97] | <0.00001 |
| YQG plus antihypertensive drugs versus antihypertensive drugs | 1 | −2.11 [−3.60, −0.62] | 0.006 |
| YQG plus indapamide versus indapamide | 1 | 0.57 [−1.39, 2.53] | 0.57 |
| YQG plus antihypertensive drugs versus antihypertensive drugs | 1 | −7.00 [−8.27, −5.73] | <0.00001 |
| YQG plus antihypertensive drugs versus antihypertensive drugs | 1 | −3.04 [−4.12, −1.96] | <0.00001 |
| Meta-analysis | 6 | −5.21 [−8.19, −2.24] | 0.0006 |